Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06938906

Multimodal Therapy Impact on Pancreatic Cancer Survival

Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
405 (actual)
Sponsor
National Cheng Kung University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main question it aims to answer is: Hypothesis: Change of treatment strategies involving increased utility of neoadjuvant chemotherapy and aggressive surgical approaches of extended pancreatectomy improved the overall and progression free survival in the patients with pancreatic cancer. Participants received curative treatment for pancreatic cancer.

Detailed description

This study is to analyze the change of treatment strategies and shift of the paradigm over time in a single center. Researchers plan to see the impact of the evolvement to the survival outcomes in pancreatic cancer.

Conditions

Timeline

Start date
2011-01-03
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2025-04-22
Last updated
2025-04-24

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06938906. Inclusion in this directory is not an endorsement.